RHI Interval Effects on Brain Health
Defining the Role of Repetitive Head Impact Time Intervals in Mitigating Subconcussive Neural Injury
1 other identifier
interventional
102
1 country
1
Brief Summary
Military service members frequently experience repetitive insults or impacts to the head (RHIs). The purpose of the proposed randomized controlled trial is to understand how time intervals affect neurological responses to repetitive subconcussive head impacts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2025
CompletedFirst Posted
Study publicly available on registry
June 8, 2025
CompletedStudy Start
First participant enrolled
August 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
May 4, 2026
April 1, 2026
3.1 years
May 30, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Blood Biomarkers - NfL
The primary outcome analyses will be comparing group differences (group x time interactions) in blood biomarkers, specifically NF-L (neurofilament light).
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Blood Biomarkers - GFAP
The primary outcome analyses will be comparing group differences (group x time interactions) in blood biomarkers, specifically GFAP (glial fibrillary acidic protein; nanograms per milliliter).
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Blood Biomarkers - pTau
The primary outcome analyses will be comparing group differences (group x time interactions) in blood biomarkers, specifically phosphorylated tau (picogram per milliliter).
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Optical Coherence Tomography/Angiography (OCT/A) 1
Retinal neural structure will be imaged in one or both eyes using high-definition spectral domain OCT, which will be acquired using a Zeiss Cirrus OCT scanner. The primary OCT variables examined will be macula CSF thickness (an indicator of the gain or loss of neurons or glia in the inner nuclear, ganglion cell and nerve fiber layer). Retinal vascular structure will be acquired using the OCT angiography (OCT/A) capability of the Cirrus.
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Optical Coherence Tomography/Angiography (OCT/A) 2
Retinal neural structure will be imaged in one or both eyes using high-definition spectral domain OCT, which will be acquired using a Zeiss Cirrus OCT scanner. The primary OCT variables examined will be cup-to-disc ratio (an indicator of neurodegeneration at the optic disc).
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Optical Coherence Tomography/Angiography (OCT/A) 3
Retinal vascular structure will be acquired using the OCT angiography (OCT/A) capability of the Cirrus. The primary OCT/A variable examined will be foveal avascular zone (FAZ) area reflecting the size of the central portion of the macula which contains no blood vessels, and which increases in size with loss of capillaries in the surrounding region).
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Quantitative Electroencephalography (qEEG)
An Investigational version of the BrainScope FDA-cleared qEEG acquisition device will be used in this study. The investigational nature of the device is simply based on the code which does not produce a diagnostic result for the blinded researcher. Thus, the manufacturer's full device indications/labeling document will be the same as the FDA-cleared version. An eyes-closed resting EEG will be recorded. An FDA cleared multivariate EEG marker of concussion, the Concussion Index (CI) will be used as input for this study modeling. The CI includes measures of power (absolute and relative), mean frequency, connectivity (asymmetry, coherence, phase lag, phase synchrony), complexity (fractal dimension and scale-free activity), and information theory (entropy), across and within frequency bands. Other features of interest will be included in the EEG data set. We will use all variables in a single model to analyze which variable, to what extent, contributed to group differences.
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Secondary Outcomes (9)
Near Point of Convergence (NPC)
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Pupillary Size Measurement and Reactivity 1
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Pupillary Size Measurement and Reactivity 2
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Pupillary Size Measurement and Reactivity 3
Baseline, 24 hours following the final heading session, 14 days following the final heading session
Pupillary Size Measurement and Reactivity 4
Baseline, 24 hours following the final heading session, 14 days following the final heading session
- +4 more secondary outcomes
Study Arms (4)
Short Interval - heading
EXPERIMENTALParticipants in the heading group will undergo 16 soccer headings, twice per week, with 24 hours in between each session.
Long Interval - heading
EXPERIMENTALParticipants in the heading group will undergo 16 soccer headings, twice per week, with 72 hours in between each session.
Short Interval - kicking
SHAM COMPARATORParticipants in the kicking-control group will undergo 16 soccer kicking, twice per week, with 24 hours in between each session.
Long Interval - kicking
SHAM COMPARATORParticipants in the kicking-control group will undergo 16 soccer kicking, twice per week, with 72 hours in between each session.
Interventions
A standardized and reliable soccer heading protocol will be used for the experiment. Participants perform 16 headers or kicking with 1 header per 30 seconds. The sessions (twice per week for 4 weeks) will be separated by 24 hours.
A standardized and reliable soccer heading protocol will be used for the experiment. Participants perform 16 headers or kicking with 1 header per 30 seconds. The sessions (twice per week for 4 weeks) will be separated by 72 hours.
An Investigational version of the BrainScope FDA-cleared qEEG acquisition device will be used in this study. The investigational nature of the device is simply based on the code which does not produce a diagnostic result for the blinded researcher. Electrodes will be placed around the participant's forehead and scalp to acquire electrical readings of brain activity.
Eligibility Criteria
You may qualify if:
- Current soccer player (intercollegiate, club, intramural, recreational).
- At least 5 years of soccer heading experience (justification below).
- Ability to provide informed consent without a legally authorized representative (LAR).
You may not qualify if:
- Any head, neck, or face injury within the 6 months prior to enrollment, including concussions, that precludes participation in contact sports.
- Participants with eye conditions or diseases that could impact the blood vessels in the eye -such as but not limited to: glaucoma, macular degeneration, diabetic retinopathy.
- Determination that the participant is unsuitable for study entry or potentially unable to complete all aspects of the study based on the judgement of the Investigator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- United States Department of Defensecollaborator
- University of Rochestercollaborator
- Boston Children's Hospitalcollaborator
- University at Buffalocollaborator
Study Sites (1)
Indiana University School of Public Health
Bloomington, Indiana, 47405, United States
Related Publications (12)
Marchi N, Bazarian JJ, Puvenna V, Janigro M, Ghosh C, Zhong J, Zhu T, Blackman E, Stewart D, Ellis J, Butler R, Janigro D. Consequences of repeated blood-brain barrier disruption in football players. PLoS One. 2013;8(3):e56805. doi: 10.1371/journal.pone.0056805. Epub 2013 Mar 6.
PMID: 23483891BACKGROUNDKawata K, Rubin LH, Takahagi M, Lee JH, Sim T, Szwanki V, Bellamy A, Tierney R, Langford D. Subconcussive Impact-Dependent Increase in Plasma S100beta Levels in Collegiate Football Players. J Neurotrauma. 2017 Jul 15;34(14):2254-2260. doi: 10.1089/neu.2016.4786. Epub 2017 Apr 27.
PMID: 28181857BACKGROUNDPuvenna V, Brennan C, Shaw G, Yang C, Marchi N, Bazarian JJ, Merchant-Borna K, Janigro D. Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits. PLoS One. 2014 May 7;9(5):e96296. doi: 10.1371/journal.pone.0096296. eCollection 2014.
PMID: 24806476BACKGROUNDOliver JM, Jones MT, Kirk KM, Gable DA, Repshas JT, Johnson TA, Andreasson U, Norgren N, Blennow K, Zetterberg H. Serum Neurofilament Light in American Football Athletes over the Course of a Season. J Neurotrauma. 2016 Oct 1;33(19):1784-1789. doi: 10.1089/neu.2015.4295. Epub 2016 Mar 16.
PMID: 26700106BACKGROUNDOliver JM, Anzalone AJ, Stone JD, Turner SM, Blueitt D, Garrison JC, Askow AT, Luedke JA, Jagim AR. Fluctuations in blood biomarkers of head trauma in NCAA football athletes over the course of a season. J Neurosurg. 2018 May 29;130(5):1655-1662. doi: 10.3171/2017.12.JNS172035. Print 2019 May 1.
PMID: 29807487BACKGROUNDShahim P, Zetterberg H, Tegner Y, Blennow K. Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology. 2017 May 9;88(19):1788-1794. doi: 10.1212/WNL.0000000000003912. Epub 2017 Apr 12.
PMID: 28404801BACKGROUNDJoseph JR, Swallow JS, Willsey K, Lapointe AP, Khalatbari S, Korley FK, Oppenlander ME, Park P, Szerlip NJ, Broglio SP. Elevated markers of brain injury as a result of clinically asymptomatic high-acceleration head impacts in high-school football athletes. J Neurosurg. 2018 Jul 3;130(5):1642-1648. doi: 10.3171/2017.12.JNS172386. Print 2019 May 1.
PMID: 29966462BACKGROUNDTierney GJ, Higgins B. The incidence and mechanism of heading in European professional football players over three seasons. Scand J Med Sci Sports. 2021 Apr;31(4):875-883. doi: 10.1111/sms.13900. Epub 2021 Jan 18.
PMID: 33280186BACKGROUNDPeek K, Vella T, Meyer T, Beaudouin F, McKay M. The incidence and characteristics of purposeful heading in male and female youth football (soccer) within Australia. J Sci Med Sport. 2021 Jun;24(6):603-608. doi: 10.1016/j.jsams.2020.12.010. Epub 2020 Dec 26.
PMID: 33414022BACKGROUNDRussell ER, Mackay DF, Stewart K, MacLean JA, Pell JP, Stewart W. Association of Field Position and Career Length With Risk of Neurodegenerative Disease in Male Former Professional Soccer Players. JAMA Neurol. 2021 Sep 1;78(9):1057-1063. doi: 10.1001/jamaneurol.2021.2403.
PMID: 34338724BACKGROUNDMackay DF, Russell ER, Stewart K, MacLean JA, Pell JP, Stewart W. Neurodegenerative Disease Mortality among Former Professional Soccer Players. N Engl J Med. 2019 Nov 7;381(19):1801-1808. doi: 10.1056/NEJMoa1908483. Epub 2019 Oct 21.
PMID: 31633894BACKGROUNDKawata K, Tierney R, Phillips J, Jeka JJ. Effect of Repetitive Sub-concussive Head Impacts on Ocular Near Point of Convergence. Int J Sports Med. 2016 May;37(5):405-10. doi: 10.1055/s-0035-1569290. Epub 2016 Feb 9.
PMID: 26859643BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Keisuke Kawata, PhD
Indiana University Bloomington Department of Kineseology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The blood biomarker experimentalist and lead statistician will be masked throughout the trial.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 30, 2025
First Posted
June 8, 2025
Study Start
August 5, 2025
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share